InvestorsHub Logo
icon url

learningcurve2020

03/12/21 8:59 AM

#30892 RE: microcapbiotech #30891

Maybe the Worst CEO ever.

>>Marker Therapeutics Inc (NASDAQ: MRKR) priced an underwritten public offering of 28.57 million common shares at $1.75 per share, representing a 31% discount from the last close price of $2.53 on Thursday.